Open Source Drug Discovery
Open Source Drug Discovery is a Council of Scientific and Industrial Research, India-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Open Source Drug Discovery, India, covering academic research published from 2001 to 2025. Read More.
Open Access Percentage
59%
Total
Publications
193
Total Open
Publications
114
Total
Citations
7.6K
Open Access
Percentage
59%
Total
Publications
193
Total Open
Publications
114
Total
Citations
7.6K
Breakdown
Publisher Open
22%
Both
30%
Other Platform Open
6%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
48
Hybrid 29%
29
No Guarantees 23%
23
Other Platform Open
Domain 65%
45
Institution 46%
32
Other Internet 13%
9
Public 9%
6
Preprint 4%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 48 |
doaj.org OAI-PMH Repository | Institution | 18 |
DOI | Other Internet | 8 |
Figshare | Public | 6 |
Europe PMC | Domain | 5 |
University of Oxford | Institution | 2 |
University of Groningen | Institution | 2 |
University of Denver | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
utwente.nl OAI-PMH Repository | Institution | 1 |